Business
Yes, Zimbabwe can
IPN Opinion article
President Obama's offer of AIDS relief to Zimbabwe is conditional on it not going anywhere near the pockets of Mugabe and his gang. But the good news is that there are many things Zimbabweans can do themselves to restore prosperity, even with Robert Mugabe still at the helm: all is not lost, despite the horrors of recent years. This author is part of a group of African think-tanks that compiled a list of practical and relatively simple policy recommendations for recovery in the recent The Zimbabwe Papers.
Europe's free, state-run health care has drawbacks
IPN News coverage
IPN's Philip Stevens comments on what lessons the US can learn from Europe as it reforms its health sector.
Be afraid of a replay of '70s-style protectionism
IPN Opinion article
WORLD leaders have pledged that there will be no repeat of the 1930s, when tit-for-tat protectionism turned a recession caused by the Wall Street crash into a decade-long depression. But it is a replay of the creeping protectionism of the 1970s that we should worry about.
Zimbabwe: Keeping hope alive in time of Cholera
IPN Opinion article
Zimbabwe can recover - if its people are allowed to. For all the catastrophic policies of President Robert Mugabe, there are still enough experienced and dedicated business people, judges, civil servants and even policemen to make the country work again once the right freedoms are in place.
Fueling waste and corruption: U.S. aid hurts poor more than helps
IPN Opinion article
President Obama has revamped the Bush policy of heath aid to poor countries by widening its scope beyond AIDS to all diseases: it looks like a great idea but it is full of unintended consequences.
Corruption fuels spread of fake drugs business
IPN Opinion article
A barrage of email spam highlights the dangers from bad drugs as everyone worries about swine flu but the plague of counterfeits is constant threat everywhere and particularly in poor countries. Taxes and corruption make business difficult or impossible for legitimate medicines but open the field to counterfeit dealers who can pay the bribes and make huge profits on their cheap imitations.
This healthcare 'reform' will kill thousands
IPN Opinion article
Before the USA institutes a federal body for 'comparative effectiveness' review of new medical treatments, it should take a look at England's rationing body NICE - which has denied innovative medicines to thousands of patients.
